Dr. Sanket Mishra wins BioCrossroads New 23 Pair Award

Sanket Mishra

Congratulations to Dr. Sanket Mishra, a former member of the Blagg lab, who was awarded the BioCrossroads new 23 Pair Award. The 23 Pair (Promising Achievers in Innovation and Research)  is a new recognition program that will celebrate and promote the state’s next generation of life sciences leaders. 23 Pair BioCrossroads advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start-ups; building new enterprises; and educating through conferences, reports and market development knowledge.  …

Read More

Sean Cocchia Rare Disease Research Grant Opportunity

Sean Cocchia Rare Disease Research Grant Opportunity

 

Applications due April 1, 2021.

 

 

Thanks to a gift from a benefactor, Sean Cocchia, we are offering one-time grants (up to $25,000) for research aimed at facilitating discoveries in rare disease research, which can include and is not limited to mechanistic studies, drug development, and/or related processes. The grants will provide financial support to conduct research during the 2020-2021 academic year. I ask that you disseminate this request for applications to members of your research team and other groups that you feel qualified to work in this area of research.

Read More

Leahy-Filipi Family Endowment for Excellence in Neuroscience Research

Leahy-Filipi Family Endowment for Excellence in Neuroscience Research

 

Funding is available through the Leahy-Filipi Family, Notre Dame alumni, to support research in neuroscience. This fellowship will provide a $10,000 fellowship. 

Overall Goals of Leahy Filipi Family Endowment for Excellence in Neuroscience  Research: 

Read More

WFCDD RFA Request for Applications-Now Open

The Warren Center for Drug Discovery invites new proposals for projects that are associated with drug discovery. In particular, projects associated with small molecule synthesis (libraries or molecular probes), hit validation, lead optimization, mid-sized scale up, assay development, protein purification, and ADMET screening. Any disease areas will be considered. Collaborative opportunities exist for the preparation of small molecules and/or computational-derived drug discovery via three cores: Chemical Synthesis & Drug Discovery, Computer-Aided Molecular Design, or Biological Screening and Development core. …

Read More

Welter Family Fellowship

Veronica Hubble, a graduate student in the Melander lab, is the first recipient of the Welter Family graduate fellowship for research on Cystic Fibrous. The Welter Family Fellowship in Science provides financial support to conduct research during the 2019 academic year. This fellowship is aimed at facilitating discoveries in cystic fibrosis research, which can include mechanistic studies, drug development, and/or related diseases that affect those with CF (eg. infections of the lung). Veronica’s proposal was entitled “Using small molecule adjuvants to combat antibiotic resistant bacteria in cystic fibrosis.”

Read More

Spring 2019 The Warren Roundup

As the 2018 academic year comes to an end, a summary of this year's accomplishments is provided in the annual Warren Roundup. First of all, several lead compounds have been identified by Notre Dame researchers and are undergoing preclinical evaluation, in hopes of identifying investigational new drugs (IND) for clinical evaluation.  …

Read More

Rare Disease Day 2017 and Rare Disease Research within the Warren Center

Rare Disease Day takes place annually on the last day of February. Its goal is to raise awareness amongst the general public and policy-makers. Global Genes maintains the RARE List™ of 7,000 rare diseases defined in the United States where a prevalence of less than 200,000 cases is the primary criteria. With about 25M Americans affected by a rare disease and the potential to increase our understanding of more common afflictions, rare disease research is a key to better health for all of us.…

Read More

Warren Family Center hosted a visitor from Novartis Pharmaceutical Corporation

Warren Family Center hosted a visitors from Novartis Pharmaceutical Corporation including Susan Giacalone (Area Scientific Associate Director- Field Medical MSL, Rare Diseases), Julio Fernandez (Field Medical National Director, Rare Diseases), John Murry, (Regional Scientific Director), Beth Ostergard Stillwell (Oncology Regional Scientific Director).…

Read More